Form RW WD - Withdrawal of Registration Withdrawal Request
03 October 2023 - 12:42PM
Edgar (US Regulatory)
October 3, 2023
VIA
EDGAR
U.S. Securities and Exchange Commission
Division of
Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Registration Statement on Form S-3 (File
No. 333-274733)
Dear Sir or Madam:
Pursuant to Rule 477 under the Securities Act of 1933, as amended, Renalytix plc (the Company) hereby requests withdrawal,
effective immediately, of its Withdrawal Request dated October 2, 2023 filed on Form RW with respect to the above-referenced Registration Statement. The Withdrawal Request was incorrectly filed on EDGAR by the Company as a Withdrawal Request
for the Registration Statement (Form RW) rather than as Correspondence with respect to the withdrawal of the Companys prior acceleration request. To be clear, the Company is not requesting to withdraw the above registration statement, merely
the Form RW that was incorrectly tagged.
Please contact Katie Kazem of Cooley LLP at (703) 456 8043, counsel to the Company, if there are any questions
regarding this matter.
|
|
|
Very truly yours, |
|
RENALYTIX PLC |
|
|
By: |
|
/s/ James McCullough |
|
|
James McCullough |
|
|
Chief Executive Officer |
Renalytix (PK) (USOTC:RTNXF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Renalytix (PK) (USOTC:RTNXF)
Historical Stock Chart
From Jul 2023 to Jul 2024